New patient portal widget
Marketing wants a third-party chatbot. CM-4 analysis flags possible ePHI in transcripts and requires BAA, data-flow limits, and logging before approval.
CM-4 requires analyzing changes to the system to determine potential security and privacy impacts prior to change implementation. In healthcare, a harmless-looking report enablement can create bulk ePHI export paths; a cipher suite change can break HIE connectivity; a new Azure AD group can grant clinic-wide chart access. Impact analysis is how CM-3 approvals become informed.
Identify confidentiality, integrity, availability, and privacy impacts of proposed changes to ePHI environments before those changes go live — and document residual risk and required compensating controls.
How this control shows up in healthcare and HIPAA-covered environments.
Marketing wants a third-party chatbot. CM-4 analysis flags possible ePHI in transcripts and requires BAA, data-flow limits, and logging before approval.
IAM change adds emergency department float pool to a cardiology EHR template. Impact analysis catches excess ePHI access; role is redesigned before production.
Availability impact to lab partners is analyzed; staged rollout and monitoring planned so results delivery does not fail silently.
Auditors look for evidence that security/privacy impacts were considered before changes affecting ePHI. Empty checkboxes fail; thoughtful analysis records pass.
How this NIST control supports HIPAA Security Rule expectations.
No. CM-4 is change-scoped impact analysis; enterprise risk analysis (RA-3 / HIPAA) is broader. Material findings should feed the enterprise view.
Pre-analyze standard changes when cataloged; still confirm each use stays within the pre-assessed bounds.
CM-3 is the change control process; CM-4 is the impact analysis that informs CM-3 decisions.
Related controls that commonly accompany CM-4.
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.